Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells
Spalinger, M. R.; Hai, R.; Li, J.; Santos, A. N.; Nordgren, T. M.; Tremblay, M. L.; Eckmann, L.; Hanson, E.; Scharl, M.; Wu, X.; Boland, B. S.; McCole, D. F.
Show abstract
Coronavirus disease (COVID-19), caused by SARS-CoV-2, has affected over 65 million individuals and killed over 1.5 million persons (December 8, 2020; www.who.int)1. While fatality rates are higher among the elderly and those with underlying comorbidities2, host factors that promote susceptibility to SARS-CoV-2 infection and severe disease are poorly understood. Although individuals with certain autoimmune/inflammatory disorders show increased susceptibility to viral infections, there is incomplete knowledge of SARS-CoV-2 susceptibility in these diseases.3-7 We report that the autoimmune PTPN2 risk variant rs1893217 promotes expression of the SARS-CoV-2 receptor, ACE2, and increases cellular entry mediated by SARS-CoV-2 spike protein. Elevated ACE2 expression and viral entry were mediated by increased JAK-STAT signalling, and were reversed by the JAK inhibitor, tofacitinib. Collectively, our findings uncover a novel risk biomarker for increased expression of the SARS-CoV-2 receptor and viral entry, and identify a clinically approved therapeutic agent to mitigate this risk.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Targeting Specific Kinase Substrates Rescues Increased Colitis Severity Induced by the Crohn's Disease-Linked LRRK2-N2081D Variant 96%
- Microbial signals and lymphotoxin drive TNF-independent death of A20 and ABIN-1 deficient epithelium 95%
- Intestinal epithelial MHC class II regulation by HDAC3 instructs microbiota-specific CD4+ T cells 94%
Similar papers in this journal
- Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling 94%
- Fatty acids produced by the gut microbiota dampen host inflammatory responses by modulating intestinal SUMOylation 93%
- Staphylococcus warneri dampens SUMOylation and promotes intestinal inflammation 92%
Similar papers in this journal
- Tofacitinib uptake by patient-derived intestinal organoids predicts individual clinical responsiveness 96%
- γδ intraepithelial lymphocytes facilitate pathological epithelial cell shedding via CD103-mediated granzyme release. 95%
- SMAD4 suppresses colitis-associated carcinoma through inhibition of CCL20/CCR6-mediated inflammation 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.